Workflow
Alnylam (ALNY) Reports Q2 Earnings: What Key Metrics Have to Say
ALNYAlnylam Pharmaceuticals(ALNY) ZACKS·2024-08-01 16:30

For the quarter ended June 2024, Alnylam Pharmaceuticals (ALNY) reported revenue of 659.83million,up107659.83 million, up 107% over the same period last year. EPS came in at 0.56, compared to -2.21intheyear−agoquarter.ThereportedrevenuecomparestotheZacksConsensusEstimateof2.21 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of 448.44 million, representing a surprise of +47.14%. The company delivered an EPS surprise of +175.68%, with the consensus EPS estimate being -$0.74.While investors closely watch year-over-year changes in headline numbers -- revenue and earn ...